Drug
Single Bond Universal
Single Bond Universal is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_3
1
33%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
Active, not recruiting1
Completed1
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
active_not_recruiting133%
completed133%
unknown133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingnot_applicable
Radiographic Evaluation of Adaptation of Universal Adhesives
NCT05907928
unknownnot_applicable
Clinical Evaluation of Different Universal Adhesive Systems in Non-carious Cervical Lesions.
NCT04707898
completedphase_3
Efficacy of Seventh Generation Bonding Agents as Short-Term Desensitizers Among Patients With Hypersensitivity
NCT04225247
Clinical Trials (3)
Showing 3 of 3 trials
NCT05907928Not Applicable
Radiographic Evaluation of Adaptation of Universal Adhesives
NCT04707898Not Applicable
Clinical Evaluation of Different Universal Adhesive Systems in Non-carious Cervical Lesions.
NCT04225247Phase 3
Efficacy of Seventh Generation Bonding Agents as Short-Term Desensitizers Among Patients With Hypersensitivity
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3